Implementing Digital Therapeutics in Practice

Press Release

Enabling DTx implementation and patient access to this category of medicine.

This framework provides healthcare decision makers (HCDM) with an industry-level guide to measuring the effectiveness of practices used to implement digital therapeutic (DTx) products in clinical settings.

The Digital Therapeutics Alliance does not provide advice on optimal business models or strategies for specific DTx products.

Payors are encouraged to use this framework for all DTx product types, with the recognition that each product has specific considerations to enable end user success.

The integration guide can be found below:

© 2024 MJH Life Sciences

All rights reserved.